Friday 18th August 2023 |
Text too small? |
Scentian Bio operates in the bio sensor part of the information technologies sector. It specialises in rapid and objective detection of taste and smell factors, was formed in 2020, and is classified as seed stage, with its technology originating from Plant and Food Research.
BIF will make a cash investment of $200,000. Following this transaction (and issue of additional units to fund the purchase), Scentian Bio will represent 1.2% of BIF’s investment portfolio of over 30 companies, and with a net asset value of over $16.9 million.
Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of the process described in the fund’s Product Disclosure Statement (PDS) that is available at www.booster.co.nz
For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-innovation-fund.aspx
For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300
About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of the Booster Group which has been helping New Zealanders save since 1998. The group currently administers superannuation and investment funds of over $5 billion on behalf of more than 190,000 New Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement, please visit www.booster.co.nz
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b